title: Injectable calcium sulfate/mineralized collagen-based bone repair materials with regulable self-setting properties.
abstract: An injectable and self-setting bone repair materials (nano-hydroxyapatite/collagen/calcium sulfate hemihydrate, nHAC/CSH) was developed in this study. The nano-hydroxyapatite/collagen (nHAC) composite, which is the mineralized fibril by self-assembly of nano-hydrocyapatite and collagen, has the same features as natural bone in both main hierarchical microstructure and composition. It is a bioactive osteoconductor due to its high level of biocompatibility and appropriate degradation rate. However, this material lacks handling characteristics because of its particle or solid-preformed block shape. Herein, calcium sulfate hemihydrate (CSH) was introduced into nHAC to prepare an injectable and self-setting in situ bone repair materials. The morphology of materials was observed using SEM. Most important and interesting of all, calcium sulfate dihydrate (CSD), which is not only the reactant of preparing CSH but also the final solidified product of CSH, was introduced into nHAC as setting accelerator to regulate self-setting properties of injectable nHAC/CSH composite, and thus the self-setting time of nHAC/CSH composite can be regulated from more than 100 min to about 30 min and even less than 20 min by adding various amount of setting accelerator. The compressive properties of bone graft substitute after final setting are similar to those of cancellous bone. CSD as an excellent setting accelerator has no significant effect on the mechanical property and degradability of bone repair materials. In vitro biocompatibility and in vivo histology studies demonstrated that the nHAC/CSH composite could provide more adequate stimulus for cell adhesion and proliferation, embodying favorable cell biocompatibility and a strong ability to accelerate bone formation. It can offer a satisfactory biological environment for growing new bone in the implants and for stimulating bone formation.
authors.affiliation: National Glycoengineering Research Center, Shandong University, Jinan, 250100, People's Republic of China. chenzg2008@163.com
authors.forename: Zonggang
authors.initials: Z
authors.lastname: Chen
authors.forename: Huanye
authors.initials: H
authors.lastname: Liu
authors.forename: Xi
authors.initials: X
authors.lastname: Liu
authors.forename: Fu-Zhai
authors.initials: FZ
authors.lastname: Cui
mesh_terms: D000818:Animals; D001672:Biocompatible Materials / Q000008:administration & dosage / Q000737:chemistry*; D001854:Bone Marrow Cells / Q000166:cytology; D018786:Bone Substitutes / Q000008:administration & dosage / Q000737:chemistry*; D001842:Bone and Bones / Q000166:cytology / Q000502:physiology*; D002133:Calcium Sulfate / Q000008:administration & dosage / Q000737:chemistry*; D002478:Cells, Cultured; D003094:Collagen / Q000008:administration & dosage / Q000737:chemistry*; D006801:Humans; D006882:Hydroxyapatites / Q000737:chemistry; D007267:Injections; D008422:Materials Testing; D010012:Osteogenesis / Q000502:physiology*; D011817:Rabbits; D012038:Regeneration / Q000502:physiology; D017154:Stromal Cells / Q000166:cytology
chemical_list: D001672:Biocompatible Materials; D018786:Bone Substitutes; D006882:Hydroxyapatites; D003094:Collagen; D002133:Calcium Sulfate